首页 > 最新文献

International Journal of Geriatric Psychiatry最新文献

英文 中文
Uniting Minds in Psychiatry and Geriatrics: Integrative Approaches to Addressing the Depression-Dementia Link Through Proactive Medicine 精神病学和老年医学的思想统一:通过积极主动的医学综合方法解决抑郁症与痴呆症之间的联系。
IF 3.6 3区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2024-08-12 DOI: 10.1002/gps.6136
Mariangela Boccardi, Virginia Boccardi
{"title":"Uniting Minds in Psychiatry and Geriatrics: Integrative Approaches to Addressing the Depression-Dementia Link Through Proactive Medicine","authors":"Mariangela Boccardi, Virginia Boccardi","doi":"10.1002/gps.6136","DOIUrl":"10.1002/gps.6136","url":null,"abstract":"","PeriodicalId":14060,"journal":{"name":"International Journal of Geriatric Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141971098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Temporal Persistence of Loneliness on Dementia: A Longitudinal Analysis From the Hunter Community Study 孤独感的时间持续性对痴呆症的影响:亨特社区研究的纵向分析
IF 3.6 3区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2024-08-10 DOI: 10.1002/gps.6132
Kay Khaing, Xenia Dolja-Gore, Balakrishnan R. Nair, Julie Byles, John Attia

Objectives

Loneliness is common and becoming a public health concern. Although there is the clear evidence of the variable effect of temporal differences in loneliness (transient/situational and persistent/chronic) on health, their effect on dementia risk is unclear. This study aims to assess the effect of transient/situational and persistent/chronic loneliness on dementia risk.

Method

Participants aged 55 years and older from the Hunter Community Study were recruited. Loneliness was measured using a single item measure. Dementia was defined as per International Classification of Disease—10 (ICD 10) codes. The Fine-Gray subdistribution hazard model was performed to calculate dementia risk.

Results

Of 1968 total participants with mean age of 66 years, (3%) 57 developed dementia and (7%) 135 died over the mean follow up of 10 years. Both persistent/chronic and transient/situational loneliness significantly increased the risk of all cause dementia in adjusted models (HR 2.74, 95% CI 1.11–6.88, p 0.03 and HR 2.35, 95% CI 1.21–4.55, p 0.01 respectively) with mean time to event of 9.7 years. Feeling lonely below the age of 70 years elevated the risk of dementia in later life (HR 4.01, 95% CI 1.40–11.50, p 0.01).

Conclusions

Loneliness (both persistent/chronic and transient/situational) was associated with increased risk of all cause dementia, especially if loneliness was experienced before the age of 70 years. These results suggest that promoting coping strategies for loneliness especially in persons 70 years and younger may play a role in preventing dementia.

目的:孤独是一种常见的现象,并已成为一个公共健康问题。尽管有明确证据表明,孤独感的时间差异(短暂/情景性和持续/慢性)对健康的影响各不相同,但它们对痴呆症风险的影响尚不明确。本研究旨在评估短暂/情境性和持续/慢性孤独感对痴呆症风险的影响:方法:从猎人社区研究中招募 55 岁及以上的参与者。孤独感采用单项测量法进行测量。痴呆症根据《国际疾病分类-10》(ICD 10)代码进行定义。采用 Fine-Gray 子分布危险模型计算痴呆症风险:在 1968 名平均年龄为 66 岁的参与者中,有 57 人(3%)患上了痴呆症,135 人(7%)在 10 年的平均随访期间死亡。在调整模型中,持续/慢性孤独感和短暂/情景性孤独感都会显著增加所有原因痴呆症的风险(分别为 HR 2.74,95% CI 1.11-6.88,p 0.03 和 HR 2.35,95% CI 1.21-4.55,p 0.01),平均发生时间为 9.7 年。70岁以下的孤独感会增加晚年痴呆症的风险(HR 4.01,95% CI 1.40-11.50,P 0.01):结论:孤独感(持续性/长期性和短暂性/情境性)与各种原因导致的痴呆症风险增加有关,尤其是在 70 岁之前经历过孤独感的人。这些结果表明,促进孤独感的应对策略,尤其是对 70 岁及以下的人来说,可能会在预防痴呆症方面发挥作用。
{"title":"The Effect of Temporal Persistence of Loneliness on Dementia: A Longitudinal Analysis From the Hunter Community Study","authors":"Kay Khaing,&nbsp;Xenia Dolja-Gore,&nbsp;Balakrishnan R. Nair,&nbsp;Julie Byles,&nbsp;John Attia","doi":"10.1002/gps.6132","DOIUrl":"10.1002/gps.6132","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Loneliness is common and becoming a public health concern. Although there is the clear evidence of the variable effect of temporal differences in loneliness (transient/situational and persistent/chronic) on health, their effect on dementia risk is unclear. This study aims to assess the effect of transient/situational and persistent/chronic loneliness on dementia risk.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>Participants aged 55 years and older from the Hunter Community Study were recruited. Loneliness was measured using a single item measure. Dementia was defined as per International Classification of Disease—10 (ICD 10) codes. The Fine-Gray subdistribution hazard model was performed to calculate dementia risk.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of 1968 total participants with mean age of 66 years, (3%) 57 developed dementia and (7%) 135 died over the mean follow up of 10 years. Both persistent/chronic and transient/situational loneliness significantly increased the risk of all cause dementia in adjusted models (HR 2.74, 95% CI 1.11–6.88, <i>p</i> 0.03 and HR 2.35, 95% CI 1.21–4.55, <i>p</i> 0.01 respectively) with mean time to event of 9.7 years. Feeling lonely below the age of 70 years elevated the risk of dementia in later life (HR 4.01, 95% CI 1.40–11.50, <i>p</i> 0.01).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Loneliness (both persistent/chronic and transient/situational) was associated with increased risk of all cause dementia, especially if loneliness was experienced before the age of 70 years. These results suggest that promoting coping strategies for loneliness especially in persons 70 years and younger may play a role in preventing dementia.</p>\u0000 </section>\u0000 </div>","PeriodicalId":14060,"journal":{"name":"International Journal of Geriatric Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gps.6132","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Outcomes of Electroconvulsive Therapy (ECT) for Depression in Older Old People Relative to Other Age Groups Across the Adult Life Span: A CARE Network Study 电休克疗法(ECT)治疗老年抑郁症的临床疗效与成人整个生命周期中其他年龄组的对比:CARE 网络研究》。
IF 3.6 3区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2024-08-09 DOI: 10.1002/gps.6133
Shanthi Sarma, Yucheng Zeng, Ana Rita Barreiros, Vanessa Dong, Clara Massaneda-Tuneu, Thanh Vinh Cao, Sue Waite, Laura K. McCosker, Grace Branjerdporn, Colleen K. Loo, Donel M. Martin

Intervention

Electroconvulsive therapy (ECT) is a commonly used treatment for severe psychiatric illness in older adults, including in the ‘older old’ population aged 80 years and above. However, there can sometimes be a reluctance to treat the 80+ year old age group with ECT due to medical comorbidities, frailty, and concerns about cognition.

Objective, Design, Setting, and Participants

This multi-site, longitudinal Australian study aimed to investigate the effectiveness and safety of ECT in older old people compared with younger age groups. Data from 310 people receiving ECT for depression at three participating hospitals was collected in a naturalistic setting, between 2015 and 2022.

Measurements

Clinical ratings were conducted pre-ECT and end-acute ECT using the Montgomery–Åsberg Depression Rating Scale (MADRS). Cognitive outcomes were assessed using the Montreal Cognitive Assessment (MoCA).

Results

Older old adults demonstrated a significant reduction MADRS scores at post-treatment. They were more likely to meet remission criteria compared with the younger age groups. Older old adults were also less likely to show clinically significant cognitive decline post-ECT, and were more likely to show clinically significant cognitive improvement post-ECT compared with younger age groups.

Conclusions

ECT is highly effective in treating severe psychiatric illness in older old adults. Relative to the younger age groups, the older old group were more likely to remit with ECT and a greater proportion showed cognitive improvement post-ECT. These findings suggest that ECT should be considered as a valuable and safe treatment option for older old individuals with depression.

干预措施:电休克疗法(ECT)是治疗老年人(包括 80 岁及以上的 "高龄 "老人)严重精神疾病的常用方法。然而,由于合并症、体弱和对认知能力的担忧,有时人们并不愿意用电休克疗法治疗 80 岁以上的老年人:这项在澳大利亚进行的多地点纵向研究旨在调查与年轻群体相比,电痉挛疗法对老年人的有效性和安全性。2015年至2022年期间,在自然环境中收集了310名因抑郁症在三家参与医院接受电痉挛疗法的患者的数据:采用蒙哥马利-阿斯伯格抑郁评定量表(MADRS)对电痉挛疗法前和急性期结束时进行临床评定。使用蒙特利尔认知评估(MoCA)对认知结果进行评估:结果:老年患者在治疗后的 MADRS 评分显著降低。与年轻人相比,他们更有可能达到缓解标准。与年轻群体相比,老年患者在接受电痉挛疗法治疗后出现临床显著认知能力下降的可能性更小,而出现临床显著认知能力改善的可能性更大:结论:电痉挛疗法治疗老年重症精神病非常有效。结论:电痉挛疗法对治疗老年重症精神病非常有效,与年轻群体相比,老年群体更有可能通过电痉挛疗法缓解病情,更多的老年群体在电痉挛疗法后认知能力得到改善。这些研究结果表明,对于患有抑郁症的老年患者来说,电痉挛疗法应被视为一种有价值且安全的治疗方法。
{"title":"Clinical Outcomes of Electroconvulsive Therapy (ECT) for Depression in Older Old People Relative to Other Age Groups Across the Adult Life Span: A CARE Network Study","authors":"Shanthi Sarma,&nbsp;Yucheng Zeng,&nbsp;Ana Rita Barreiros,&nbsp;Vanessa Dong,&nbsp;Clara Massaneda-Tuneu,&nbsp;Thanh Vinh Cao,&nbsp;Sue Waite,&nbsp;Laura K. McCosker,&nbsp;Grace Branjerdporn,&nbsp;Colleen K. Loo,&nbsp;Donel M. Martin","doi":"10.1002/gps.6133","DOIUrl":"10.1002/gps.6133","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Intervention</h3>\u0000 \u0000 <p>Electroconvulsive therapy (ECT) is a commonly used treatment for severe psychiatric illness in older adults, including in the ‘older old’ population aged 80 years and above. However, there can sometimes be a reluctance to treat the 80+ year old age group with ECT due to medical comorbidities, frailty, and concerns about cognition.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective, Design, Setting, and Participants</h3>\u0000 \u0000 <p>This multi-site, longitudinal Australian study aimed to investigate the effectiveness and safety of ECT in older old people compared with younger age groups. Data from 310 people receiving ECT for depression at three participating hospitals was collected in a naturalistic setting, between 2015 and 2022.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Measurements</h3>\u0000 \u0000 <p>Clinical ratings were conducted pre-ECT and end-acute ECT using the Montgomery–Åsberg Depression Rating Scale (MADRS). Cognitive outcomes were assessed using the Montreal Cognitive Assessment (MoCA).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Older old adults demonstrated a significant reduction MADRS scores at post-treatment. They were more likely to meet remission criteria compared with the younger age groups. Older old adults were also less likely to show clinically significant cognitive decline post-ECT, and were more likely to show clinically significant cognitive improvement post-ECT compared with younger age groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>ECT is highly effective in treating severe psychiatric illness in older old adults. Relative to the younger age groups, the older old group were more likely to remit with ECT and a greater proportion showed cognitive improvement post-ECT. These findings suggest that ECT should be considered as a valuable and safe treatment option for older old individuals with depression.</p>\u0000 </section>\u0000 </div>","PeriodicalId":14060,"journal":{"name":"International Journal of Geriatric Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gps.6133","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimating the Prevalence of Dementia in New Zealand Using Capture-Recapture Analysis on Routinely Collected Health Data 通过对常规收集的健康数据进行捕获-再捕获分析,估算新西兰痴呆症的患病率。
IF 3.6 3区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2024-08-09 DOI: 10.1002/gps.6131
E. Ma'u, S. Cullum, N. Mukadam, D. Davis, C. Rivera-Rodriguez, G. Cheung

Objectives

Community based dementia prevalence studies are expensive and resource intensive. Aotearoa New Zealand (NZ) has never had a community based dementia prevalence study representing all major ethnic groups. In recent years, dementia prevalence estimates have been derived from routinely collected health data but issues of underdiagnosis and undercoding limit their utility. Capture-recapture techniques can estimate the number of dementia cases missing from health datasets by modelling the ascertained overlaps between linked data sources.

Methods

Three routinely collected national health data sets—interRAI, Public hospital discharges, and Pharmaceuticals—were linked and all prevalent cases of dementia in NZ for the year 1 January 2021–31 December 2021 were identified. Capture-recapture analysis fitted eight loglinear models to the data, with the best fitting model used to estimate the number of prevalent cases missing from all three datasets.

Results

We estimated that almost half (47.8%) of dementia cases are not present in any of the three datasets. Dementia prevalence increased from 3.7% to 7.1% (95% CI 6.9%–7.4%) in the NZ 60+ population and from 4.9% to 9.2% (95% CI 8.9%–9.6%) in the NZ 65+ population when missing cases were included. Estimates of missing cases were significantly higher (p < 0.001) in Māori (49.2%), Pacific peoples (50.6%) and Asian (59.6%) compared to Europeans (46.4%).

Conclusions

This study provides updated estimates of dementia prevalence in NZ and the proportion of undiagnosed dementia in NZ, highlighting the need for better access to dementia assessment and diagnosis.

目的:以社区为基础的痴呆症患病率研究耗资巨大、资源密集。奥特亚罗瓦新西兰(Aotearoa New Zealand,NZ)从未开展过代表所有主要种族群体的社区痴呆症患病率研究。近年来,痴呆症患病率的估计值来自常规收集的健康数据,但诊断不足和编码不足的问题限制了这些数据的实用性。捕获-再捕获技术可通过对关联数据源之间已确定的重叠进行建模,估算出健康数据集中缺失的痴呆症病例数:方法:将三个常规收集的国家健康数据集--interRAI、公立医院出院病例和药品数据集连接起来,并确定 2021 年 1 月 1 日至 2021 年 12 月 31 日期间新西兰的所有痴呆症流行病例。捕获-再捕获分析对数据拟合了八个对数线性模型,并利用拟合效果最好的模型来估算所有三个数据集中缺失的流行病例数量:我们估计,几乎有一半(47.8%)的痴呆症病例在三个数据集中都不存在。如果将缺失病例包括在内,新西兰60岁以上人口的痴呆症患病率将从3.7%上升至7.1%(95% CI为6.9%-7.4%),新西兰65岁以上人口的患病率将从4.9%上升至9.2%(95% CI为8.9%-9.6%)。缺失病例的估计值明显更高(p 结论:该研究提供了痴呆症发病率的最新估计值:这项研究提供了新西兰痴呆症患病率的最新估计值以及新西兰未确诊痴呆症的比例,强调了更好地进行痴呆症评估和诊断的必要性。
{"title":"Estimating the Prevalence of Dementia in New Zealand Using Capture-Recapture Analysis on Routinely Collected Health Data","authors":"E. Ma'u,&nbsp;S. Cullum,&nbsp;N. Mukadam,&nbsp;D. Davis,&nbsp;C. Rivera-Rodriguez,&nbsp;G. Cheung","doi":"10.1002/gps.6131","DOIUrl":"10.1002/gps.6131","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Community based dementia prevalence studies are expensive and resource intensive. Aotearoa New Zealand (NZ) has never had a community based dementia prevalence study representing all major ethnic groups. In recent years, dementia prevalence estimates have been derived from routinely collected health data but issues of underdiagnosis and undercoding limit their utility. Capture-recapture techniques can estimate the number of dementia cases missing from health datasets by modelling the ascertained overlaps between linked data sources.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Three routinely collected national health data sets—interRAI, Public hospital discharges, and Pharmaceuticals—were linked and all prevalent cases of dementia in NZ for the year 1 January 2021–31 December 2021 were identified. Capture-recapture analysis fitted eight loglinear models to the data, with the best fitting model used to estimate the number of prevalent cases missing from all three datasets.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>We estimated that almost half (47.8%) of dementia cases are not present in any of the three datasets. Dementia prevalence increased from 3.7% to 7.1% (95% CI 6.9%–7.4%) in the NZ 60+ population and from 4.9% to 9.2% (95% CI 8.9%–9.6%) in the NZ 65+ population when missing cases were included. Estimates of missing cases were significantly higher (<i>p</i> &lt; 0.001) in Māori (49.2%), Pacific peoples (50.6%) and Asian (59.6%) compared to Europeans (46.4%).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This study provides updated estimates of dementia prevalence in NZ and the proportion of undiagnosed dementia in NZ, highlighting the need for better access to dementia assessment and diagnosis.</p>\u0000 </section>\u0000 </div>","PeriodicalId":14060,"journal":{"name":"International Journal of Geriatric Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gps.6131","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141912544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-Pharmacological Interventions in the Management of Dementia-Related Psychosis: A Systematic Review and Meta-Analysis 痴呆症相关精神病治疗中的非药物干预:系统回顾与元分析》。
IF 3.6 3区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2024-08-07 DOI: 10.1002/gps.6129
Alice Burnand, Tasmin Rookes, Farah Mahmood, Nathan Davies, Kate Walters, Stephen Orleans-Foli, Madiha Sajid, Victoria Vickerstaff, Rachael Frost

Objective

As populations age globally, there is an increasing prevalence of dementia, with an estimated 153 million living with dementia by 2050. Up to 70% of people with dementia experience dementia-related psychosis (D-RP). Antipsychotic medications are associated with many adverse effects in older people. This review aims to evaluate the evidence of non-pharmacological interventions in managing D-RP.

Method

The search of Medline, EMBASE, Web of Science, CINAHL, PsycINFO, and Cochrane included randomised controlled trials that evaluated non-pharmacological interventions. Data extraction and assessment of quality were assessed independently by two researchers. Heterogenous interventions were pooled using meta-analysis.

Results

A total of 18 articles (n = 2040 participants) were included and categorised into: sensory-, activity-, cognitive- and multi-component-orientated. Meta-analyses showed no significant impact in reducing hallucinations or delusions but person-centred care, cognitive rehabilitation, music therapy, and robot pets showed promise in single studies.

Conclusions and Implications

Future interventions should be developed and evaluated with a specific focus on D-RP as this was not the aim for many of the included articles.

目的:随着全球人口的老龄化,痴呆症的发病率越来越高,预计到 2050 年将有 1.53 亿人患有痴呆症。高达 70% 的痴呆症患者会出现痴呆症相关精神病(D-RP)。抗精神病药物对老年人有许多不良影响。本综述旨在评估非药物干预治疗 D-RP 的证据:方法:检索 Medline、EMBASE、Web of Science、CINAHL、PsycINFO 和 Cochrane,纳入评估非药物干预措施的随机对照试验。数据提取和质量评估由两名研究人员独立完成。采用荟萃分析法对异质性干预措施进行了汇总:共纳入了 18 篇文章(n = 2040 名参与者),并将其分为:以感觉为导向、以活动为导向、以认知为导向和以多组分为导向。元分析表明,在减少幻觉或妄想方面没有显著效果,但以人为本的护理、认知康复、音乐疗法和机器人宠物在单项研究中显示出了前景:未来干预措施的开发和评估应特别关注幻觉和妄想,因为这并不是许多收录文章的目标。
{"title":"Non-Pharmacological Interventions in the Management of Dementia-Related Psychosis: A Systematic Review and Meta-Analysis","authors":"Alice Burnand,&nbsp;Tasmin Rookes,&nbsp;Farah Mahmood,&nbsp;Nathan Davies,&nbsp;Kate Walters,&nbsp;Stephen Orleans-Foli,&nbsp;Madiha Sajid,&nbsp;Victoria Vickerstaff,&nbsp;Rachael Frost","doi":"10.1002/gps.6129","DOIUrl":"10.1002/gps.6129","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>As populations age globally, there is an increasing prevalence of dementia, with an estimated 153 million living with dementia by 2050. Up to 70% of people with dementia experience dementia-related psychosis (D-RP). Antipsychotic medications are associated with many adverse effects in older people. This review aims to evaluate the evidence of non-pharmacological interventions in managing D-RP.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>The search of Medline, EMBASE, Web of Science, CINAHL, PsycINFO, and Cochrane included randomised controlled trials that evaluated non-pharmacological interventions. Data extraction and assessment of quality were assessed independently by two researchers. Heterogenous interventions were pooled using meta-analysis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 18 articles (<i>n</i> = 2040 participants) were included and categorised into: sensory-, activity-, cognitive- and multi-component-orientated. Meta-analyses showed no significant impact in reducing hallucinations or delusions but person-centred care, cognitive rehabilitation, music therapy, and robot pets showed promise in single studies.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions and Implications</h3>\u0000 \u0000 <p>Future interventions should be developed and evaluated with a specific focus on D-RP as this was not the aim for many of the included articles.</p>\u0000 </section>\u0000 </div>","PeriodicalId":14060,"journal":{"name":"International Journal of Geriatric Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gps.6129","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141901712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to “Neural markers of reduced arousal and consciousness in mild cognitive impairment” 更正 "轻度认知障碍患者唤醒和意识减退的神经标记"。
IF 3.6 3区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2024-08-02 DOI: 10.1002/gps.6128

Estarellas M, Huntley J, Bor D. Neural markers of reduced arousal and consciousness in mild cognitive impairment. Int J Geriatr Psychiatry. 2024 Jun;39(6):e6112. doi: 10.1002/gps.6112. PMID: 38837281.

Upon reviewing the published version, we noticed that Figure 1 is incorrect. It appears that Figure 1 and Figure 2 are duplicates, with Figure 1 being the wrong figure. Specifically, Figure 1 was intended to represent “all data,” but the figure actually displays data for only Mild Cognitive Impairment (MCI).

Estarellas M, Huntley J, Bor D. 轻度认知障碍患者唤醒和意识减退的神经标记。Int J Geriatr Psychiatry.2024 Jun; 39(6):e6112. Doi: 10.1002/gps.6112.PMID: 38837281.在审阅发表的版本时,我们注意到图 1 不正确。图 1 和图 2 似乎是重复的,图 1 是错误的图。具体来说,图 1 本应代表 "所有数据",但实际上该图只显示了轻度认知障碍 (MCI) 的数据。
{"title":"Correction to “Neural markers of reduced arousal and consciousness in mild cognitive impairment”","authors":"","doi":"10.1002/gps.6128","DOIUrl":"10.1002/gps.6128","url":null,"abstract":"<p>Estarellas M, Huntley J, Bor D. Neural markers of reduced arousal and consciousness in mild cognitive impairment. Int J Geriatr Psychiatry. 2024 Jun;39(6):e6112. doi: 10.1002/gps.6112. PMID: 38837281.</p><p>Upon reviewing the published version, we noticed that Figure 1 is incorrect. It appears that Figure 1 and Figure 2 are duplicates, with Figure 1 being the wrong figure. Specifically, Figure 1 was intended to represent “all data,” but the figure actually displays data for only Mild Cognitive Impairment (MCI).</p>","PeriodicalId":14060,"journal":{"name":"International Journal of Geriatric Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gps.6128","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141878694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post hoc analysis of the characteristics and treatment needs of patients with dementia with Lewy bodies (DLB) and their caregivers and their physicians' awareness of those treatment needs according to the duration after diagnosis of DLB 根据路易体痴呆(DLB)确诊后的时间长短,对路易体痴呆(DLB)患者及其护理者的特征和治疗需求以及医生对这些治疗需求的认识进行事后分析。
IF 3.6 3区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2024-07-31 DOI: 10.1002/gps.6122
Manabu Ikeda, Shunji Toya, Yuta Manabe, Hajime Yamakage, Mamoru Hashimoto

Objectives

To investigate the differences in patient/caregiver characteristics, their treatment needs, and the attending physician's understanding of those treatment needs according to the duration after diagnosis of dementia with Lewy bodies (DLB).

Methods

This was a post hoc analysis of a multicenter, cross-sectional, questionnaire survey study. A total of 263 patient–caregiver pairs were reclassified into two groups according to the median duration after diagnosis of DLB as follows: short (<24 months; S-group) and long (≥24 months; L-group) post-DLB diagnosis duration. Treatment need was defined as the symptom domain that caused the patient or caregiver the most distress. Concordance rates between patient–physician and caregiver–physician were calculated for physicians' understanding of treatment needs.

Results

In this analysis, 126 pairs (32 physicians) and 137 pairs (34 physicians) were classified as the S- and L-groups, respectively. Patient and caregiver characteristics were broadly similar between groups (mean age for patients 78.7 ± 6.6 vs. 79.8 ± 6.7, for caregivers 64.7 ± 12.9 vs. 64.9 ± 12.8; number of male/female for patients 61/65 vs. 67/70, for caregivers 34/92 vs. 38/99), but the prevalence of parkinsonism (82.5% vs. 66.7%) and autonomic dysfunction (49.6% vs. 33.3%), severity of parkinsonism (MDS-UPDRS Part III total scores, 29.2 ± 22.6 vs. 18.0 ± 16.4; Part II total score, 14.6 ± 12.0 vs. 7.6 ± 7.9), and caregiver burden (J-ZBI_8 score, 9.1 ± 6.7 vs. 7.5 ± 5.8) were higher in the L-group than the S-group. Regarding treatment needs, the invalid answer rates for patients were 34.9% and 46.8%, and those for caregivers were 28.6% and 34.9% in the S- and L groups, respectively. Patients' treatment needs did not significantly differ (p = 0.056), but S-group patients were more likely to select cognitive impairment (p = 0.045) as their treatment need, whereas L-group patients were more likely to select parkinsonism (p = 0.003). Caregivers' treatment needs significantly differed (p = 0.032) between groups. S-group caregivers were more likely to select cognitive impairment (p = 0.001), whereas L-group caregivers were more likely to select other symptom domains such as parkinsonism (S-group vs. L-group: 10.3% vs. 16.7%), psychiatric symptoms (20.6% vs. 24.6%), sleep-related disorder (4.0% vs. 7.1%), and autonomic dysfunction (4.8% vs. 9.5%). Concordance rates between patient–physician and caregiver–physician were low in both groups.

目的根据路易体痴呆(DLB)确诊后的持续时间,调查患者/护理者的特征、治疗需求以及主治医生对这些治疗需求的理解的差异:这是对一项多中心、横断面、问卷调查研究的事后分析。在这项分析中,126 对(32 名医生)和 137 对(34 名医生)分别被划分为 S 组和 L 组。两组患者和护理人员的特征大致相似(患者的平均年龄为 78.7 ± 6.6 vs. 79.8 ± 6.7,护理人员的平均年龄为 64.7 ± 12.9 vs. 64.9 ± 12.8;患者的男性/女性人数为 61/65 vs. 67/70,护理人员的男性/女性人数为 34/92 vs. 38/99),但帕金森病的发病率(82.5% vs. 66.7%)和自律神经失调的发病率(66.7% vs. 66.7%)却有所差异。但 L 组的帕金森病患病率(82.5% 对 66.7%)和自主神经功能障碍患病率(49.6% 对 33.3%)、帕金森病严重程度(MDS-UPDRS 第三部分总分,29.2 ± 22.6 对 18.0 ± 16.4;第二部分总分,14.6 ± 12.0 对 7.6 ± 7.9)和护理人员负担(J-ZBI_8 评分,9.1 ± 6.7 对 7.5 ± 5.8)均高于 S 组。在治疗需求方面,S 组和 L 组患者的无效回答率分别为 34.9% 和 46.8%,护理人员的无效回答率分别为 28.6% 和 34.9%。患者的治疗需求没有明显差异(p = 0.056),但 S 组患者更倾向于选择认知障碍(p = 0.045)作为治疗需求,而 L 组患者更倾向于选择帕金森病(p = 0.003)。护理人员的治疗需求在组间存在明显差异(p = 0.032)。S 组护理人员更倾向于选择认知障碍(p = 0.001),而 L 组护理人员更倾向于选择其他症状领域,如帕金森病(S 组 vs. L 组:10.3% vs. 16.7%)、精神症状(20.6% vs. 24.6%)、睡眠相关障碍(4.0% vs. 7.1%)和自主神经功能障碍(4.8% vs. 9.5%)。两组患者-医生和护理人员-医生之间的一致性较低:结论:DLB确诊后的持续时间不同,其特征也存在一些差异。认知功能障碍可能是确诊 DLB 后不久患者和护理人员特别关注的问题。患者和照护者对帕金森病、精神症状、睡眠相关障碍或自主神经功能障碍的治疗需求因DLB确诊后的时间长短而不同。无论诊断出DLB的时间长短,医生对患者/护理者治疗需求的感知都很差:UMIN临床试验登记处(UMIN000041844)。
{"title":"Post hoc analysis of the characteristics and treatment needs of patients with dementia with Lewy bodies (DLB) and their caregivers and their physicians' awareness of those treatment needs according to the duration after diagnosis of DLB","authors":"Manabu Ikeda,&nbsp;Shunji Toya,&nbsp;Yuta Manabe,&nbsp;Hajime Yamakage,&nbsp;Mamoru Hashimoto","doi":"10.1002/gps.6122","DOIUrl":"10.1002/gps.6122","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To investigate the differences in patient/caregiver characteristics, their treatment needs, and the attending physician's understanding of those treatment needs according to the duration after diagnosis of dementia with Lewy bodies (DLB).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This was a post hoc analysis of a multicenter, cross-sectional, questionnaire survey study. A total of 263 patient–caregiver pairs were reclassified into two groups according to the median duration after diagnosis of DLB as follows: short (&lt;24 months; S-group) and long (≥24 months; L-group) post-DLB diagnosis duration. Treatment need was defined as the symptom domain that caused the patient or caregiver the most distress. Concordance rates between patient–physician and caregiver–physician were calculated for physicians' understanding of treatment needs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In this analysis, 126 pairs (32 physicians) and 137 pairs (34 physicians) were classified as the S- and L-groups, respectively. Patient and caregiver characteristics were broadly similar between groups (mean age for patients 78.7 ± 6.6 vs. 79.8 ± 6.7, for caregivers 64.7 ± 12.9 vs. 64.9 ± 12.8; number of male/female for patients 61/65 vs. 67/70, for caregivers 34/92 vs. 38/99), but the prevalence of parkinsonism (82.5% vs. 66.7%) and autonomic dysfunction (49.6% vs. 33.3%), severity of parkinsonism (MDS-UPDRS Part III total scores, 29.2 ± 22.6 vs. 18.0 ± 16.4; Part II total score, 14.6 ± 12.0 vs. 7.6 ± 7.9), and caregiver burden (J-ZBI_8 score, 9.1 ± 6.7 vs. 7.5 ± 5.8) were higher in the L-group than the S-group. Regarding treatment needs, the invalid answer rates for patients were 34.9% and 46.8%, and those for caregivers were 28.6% and 34.9% in the S- and L groups, respectively. Patients' treatment needs did not significantly differ (<i>p</i> = 0.056), but S-group patients were more likely to select cognitive impairment (<i>p</i> = 0.045) as their treatment need, whereas L-group patients were more likely to select parkinsonism (<i>p</i> = 0.003). Caregivers' treatment needs significantly differed (<i>p</i> = 0.032) between groups. S-group caregivers were more likely to select cognitive impairment (<i>p</i> = 0.001), whereas L-group caregivers were more likely to select other symptom domains such as parkinsonism (S-group vs. L-group: 10.3% vs. 16.7%), psychiatric symptoms (20.6% vs. 24.6%), sleep-related disorder (4.0% vs. 7.1%), and autonomic dysfunction (4.8% vs. 9.5%). Concordance rates between patient–physician and caregiver–physician were low in both groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 ","PeriodicalId":14060,"journal":{"name":"International Journal of Geriatric Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gps.6122","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141859729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Costs of diagnosing early Alzheimer's disease in three European memory clinic settings: Results from the precision medicine in Alzheimer's disease project 欧洲三家记忆诊所诊断早期阿尔茨海默病的成本:阿尔茨海默病精准医疗项目的结果
IF 3.6 3区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2024-07-18 DOI: 10.1002/gps.6126
Anders Wimo, Bjørn-Eivind Kirsebom, Santiago Timón-Reina, Ellen Vromen, Per Selnes, Jaka Bon, Andreja Emersic, Milica Gregoric Kramberger, Andreja Speh, Pieter Jelle Visser, Bengt Winblad, Tormod Fladby

Objectives

The implementation of disease-modifying treatments for Alzheimer's Disease (AD) will require cost-effective diagnostic processes. As part of The Precision Medicine In AD consortium (PMI-AD) project, the aim is to analyze the baseline costs of diagnosing early AD at memory clinics in Norway, Slovenia, and the Netherlands.

Methods

The costs of cognitive testing and a clinical examination, apolipoprotein E, magnetic resonance imaging (MRI), cerebrospinal fluid (CSF), positron emission tomography and blood-based biomarkers (BBM), which are used in different combinations in the three countries, were analyzed. Standardized unit costs, adjusted for GDP per capita and based on Swedish conditions were applied. The costs were expressed in euros (€) as of 2019. A diagnostic set comprising clinical examination, cognitive testing, MRI and CSF was defined as the gold standard, with MRI mainly used as an exclusion filter.

Results

Cost data were available for 994 persons in Norway, 169 in Slovenia and 1015 in the Netherlands. The mean diagnostic costs were 1478 (95% confidence interval 1433–1523) € in Norway, 851 (731–970) € in Slovenia and 1184 (1135–1232) € in the Netherlands. Norway had the highest unit costs but also the greatest use of tests. With a uniform diagnostic test set applied, the diagnostic costs were 1264 (1238–1291) €, in Norway, 843 (771–914) € in Slovenia and 1184 (1156–1213) € in the Netherlands. There were no major cost differences between the final set of diagnoses.

Conclusions

The total costs for setting a diagnosis of AD varied somewhat in the three countries, depending on unit costs and use of tests. These costs are relatively low in comparison to the societal costs of AD.

目标 针对阿尔茨海默病(AD)实施疾病改变疗法需要具有成本效益的诊断过程。作为阿兹海默病精准医疗联盟(PMI-AD)项目的一部分,该项目旨在分析挪威、斯洛文尼亚和荷兰记忆诊所诊断早期阿兹海默病的基线成本。 方法 分析了认知测试和临床检查、载脂蛋白 E、磁共振成像 (MRI)、脑脊液 (CSF)、正电子发射断层扫描和血液生物标记物 (BBM) 的成本,这三个国家采用了不同的组合。根据人均 GDP 调整后的标准化单位成本以瑞典的情况为基础。截至 2019 年的成本以欧元(€)表示。由临床检查、认知测试、核磁共振成像和脑脊液组成的诊断集被定义为金标准,核磁共振成像主要用作排除过滤器。 结果 挪威、斯洛文尼亚和荷兰分别有 994 人、169 人和 1015 人的成本数据。挪威的平均诊断成本为1478欧元(95%置信区间为1433-1523),斯洛文尼亚为851欧元(731-970),荷兰为1184欧元(1135-1232)。挪威的单位成本最高,但使用的检测项目也最多。在采用统一诊断检测组的情况下,挪威的诊断费用为 1264(1238-1291)欧元,斯洛文尼亚为 843(771-914)欧元,荷兰为 1184(1156-1213)欧元。最终诊断结果之间的成本差异不大。 结论 根据单位成本和检测项目的使用情况,三个国家确诊 AD 的总成本存在一定差异。与注意力缺失症的社会成本相比,这些成本相对较低。
{"title":"Costs of diagnosing early Alzheimer's disease in three European memory clinic settings: Results from the precision medicine in Alzheimer's disease project","authors":"Anders Wimo,&nbsp;Bjørn-Eivind Kirsebom,&nbsp;Santiago Timón-Reina,&nbsp;Ellen Vromen,&nbsp;Per Selnes,&nbsp;Jaka Bon,&nbsp;Andreja Emersic,&nbsp;Milica Gregoric Kramberger,&nbsp;Andreja Speh,&nbsp;Pieter Jelle Visser,&nbsp;Bengt Winblad,&nbsp;Tormod Fladby","doi":"10.1002/gps.6126","DOIUrl":"https://doi.org/10.1002/gps.6126","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>The implementation of disease-modifying treatments for Alzheimer's Disease (AD) will require cost-effective diagnostic processes. As part of The Precision Medicine In AD consortium (PMI-AD) project, the aim is to analyze the baseline costs of diagnosing early AD at memory clinics in Norway, Slovenia, and the Netherlands.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The costs of cognitive testing and a clinical examination, apolipoprotein E, magnetic resonance imaging (MRI), cerebrospinal fluid (CSF), positron emission tomography and blood-based biomarkers (BBM), which are used in different combinations in the three countries, were analyzed. Standardized unit costs, adjusted for GDP per capita and based on Swedish conditions were applied. The costs were expressed in euros (€) as of 2019. A diagnostic set comprising clinical examination, cognitive testing, MRI and CSF was defined as the gold standard, with MRI mainly used as an exclusion filter.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Cost data were available for 994 persons in Norway, 169 in Slovenia and 1015 in the Netherlands. The mean diagnostic costs were 1478 (95% confidence interval 1433–1523) € in Norway, 851 (731–970) € in Slovenia and 1184 (1135–1232) € in the Netherlands. Norway had the highest unit costs but also the greatest use of tests. With a uniform diagnostic test set applied, the diagnostic costs were 1264 (1238–1291) €, in Norway, 843 (771–914) € in Slovenia and 1184 (1156–1213) € in the Netherlands. There were no major cost differences between the final set of diagnoses.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The total costs for setting a diagnosis of AD varied somewhat in the three countries, depending on unit costs and use of tests. These costs are relatively low in comparison to the societal costs of AD.</p>\u0000 </section>\u0000 </div>","PeriodicalId":14060,"journal":{"name":"International Journal of Geriatric Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gps.6126","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141730205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of the COVID-19 pandemic on care-quality outcomes in older adults admitted to hospital with altered mental status COVID-19 大流行对因精神状态改变而入院的老年人护理质量结果的影响
IF 3.6 3区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2024-07-18 DOI: 10.1002/gps.6125
Adam Fluck, Christopher H. Fry, Jonathan Robin, David Fluck, Thang S. Han

Objectives

During the coronavirus disease (COVID-19) pandemic, patients with altered mental status (AMS: dementia, delirium and delirium superimposed on dementia) were profoundly affected by an abrupt transformation in healthcare systems. Here, we evaluated quality-care outcomes, including length of stay (LOS), in-hospital mortality, early readmission and mortality after hospital discharge, in older adults admitted for AMS during the pandemic and compared them to patients admitted prior to the pandemic.

Methods

Chi-squared and Fisher's exact tests were used to examine changes to admissions for AMS before and during the pandemic, and their outcomes. Logistic regression analyses, with reference to pre-pandemic data, were conducted to examine the impact of the pandemic on outcomes.

Design

Prospective data of 21,192 non-COVID admissions to an acute general medical department in a Surrey (UK) hospital were collected from patients admitted before (1st April 2019 to 29th February 2020) and during the pandemic (1st March 2020 to 31st March 2021).

Results

There were 10,173 (47.7% men) from the pre-pandemic and 11,019 (47.5% men) from the pandemic periods; overall mean age  =  68.3yr. During the pandemic AMS patients had significantly higher admission rates (1.1% vs 0.6%, P < 0.001). However, median LOS in hospital was shorter (9.0 days [IQR = 5.3–16.2] vs 15.5 days [IQR  =  6.2–25.7], P < 0.001) and thus were less likely to stay in hospital >3 weeks: adjusted OR  =  0.26 (95%CI  =  0.12–0.57). In-hospital mortality and readmission within 28 days of discharge did not change during the pandemic, but were less likely to die within 30 days of discharge: adjusted OR = 0.32 (95%CI = 0.11–0.96).

Conclusions

This combination of higher admission rate, shorter LOS, and an unchanging early readmission suggests a higher admission-discharge turnover of different patients with AMS and provides important insights into the potential impact of the COVID-19 pandemic on healthcare delivery to individuals with AMS.

目的 在冠状病毒病(COVID-19)大流行期间,精神状态改变(AMS:痴呆、谵妄和谵妄叠加痴呆)患者受到医疗系统突然转变的深刻影响。在此,我们评估了大流行期间因精神状态改变而入院的老年人的护理质量结果,包括住院时间(LOS)、院内死亡率、早期再入院率和出院后死亡率,并与大流行前入院的患者进行了比较。 方法 采用卡方检验和费雪精确检验来研究大流行前和大流行期间因急性呼吸系统综合症入院患者的变化及其结果。参照大流行前的数据进行逻辑回归分析,以研究大流行对结果的影响。 设计 收集了英国萨里郡一家医院急诊普通内科的 21,192 例非 COVID 入院患者的前瞻性数据,这些患者分别在大流行前(2019 年 4 月 1 日至 2020 年 2 月 29 日)和大流行期间(2020 年 3 月 1 日至 2021 年 3 月 31 日)入院。 大流行期间,急性髓系白血病患者的入院率明显更高(1.1% vs 0.6%,P <0.001)。然而,住院时间中位数较短(9.0 天 [IQR = 5.3-16.2] vs 15.5 天 [IQR = 6.2-25.7], P <0.001),因此住院 3 周的可能性较低:调整后 OR = 0.26 (95%CI = 0.12-0.57)。在大流行期间,住院死亡率和出院后 28 天内的再入院率没有变化,但出院后 30 天内死亡的可能性较低:调整 OR = 0.32(95%CI = 0.11-0.96)。 结论 较高的入院率、较短的生命周期和不变的早期再入院率表明,不同的急性髓系白血病患者的入院-出院周转率较高,这为了解 COVID-19 大流行对急性髓系白血病患者医疗服务的潜在影响提供了重要信息。
{"title":"Impact of the COVID-19 pandemic on care-quality outcomes in older adults admitted to hospital with altered mental status","authors":"Adam Fluck,&nbsp;Christopher H. Fry,&nbsp;Jonathan Robin,&nbsp;David Fluck,&nbsp;Thang S. Han","doi":"10.1002/gps.6125","DOIUrl":"https://doi.org/10.1002/gps.6125","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>During the coronavirus disease (COVID-19) pandemic, patients with altered mental status (AMS: dementia, delirium and delirium superimposed on dementia) were profoundly affected by an abrupt transformation in healthcare systems. Here, we evaluated quality-care outcomes, including length of stay (LOS), in-hospital mortality, early readmission and mortality after hospital discharge, in older adults admitted for AMS during the pandemic and compared them to patients admitted prior to the pandemic.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Chi-squared and Fisher's exact tests were used to examine changes to admissions for AMS before and during the pandemic, and their outcomes. Logistic regression analyses, with reference to pre-pandemic data, were conducted to examine the impact of the pandemic on outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>Prospective data of 21,192 non-COVID admissions to an acute general medical department in a Surrey (UK) hospital were collected from patients admitted before (1st April 2019 to 29th February 2020) and during the pandemic (1st March 2020 to 31st March 2021).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>There were 10,173 (47.7% men) from the pre-pandemic and 11,019 (47.5% men) from the pandemic periods; overall mean age  =  68.3yr. During the pandemic AMS patients had significantly higher admission rates (1.1% vs 0.6%, <i>P</i> &lt; 0.001). However, median LOS in hospital was shorter (9.0 days [IQR = 5.3–16.2] vs 15.5 days [IQR  =  6.2–25.7], <i>P</i> &lt; 0.001) and thus were less likely to stay in hospital &gt;3 weeks: adjusted OR  =  0.26 (95%CI  =  0.12–0.57). In-hospital mortality and readmission within 28 days of discharge did not change during the pandemic, but were less likely to die within 30 days of discharge: adjusted OR = 0.32 (95%CI = 0.11–0.96).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This combination of higher admission rate, shorter LOS, and an unchanging early readmission suggests a higher admission-discharge turnover of different patients with AMS and provides important insights into the potential impact of the COVID-19 pandemic on healthcare delivery to individuals with AMS.</p>\u0000 </section>\u0000 </div>","PeriodicalId":14060,"journal":{"name":"International Journal of Geriatric Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gps.6125","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141730206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pet ownership and psychosocial outcomes among the oldest old in Germany during the Covid-19 pandemic. Findings based on the nationally representative “Old Age in Germany (D80+)” 在 Covid-19 大流行期间,德国最年长者拥有宠物的情况和社会心理状况。调查结果基于具有全国代表性的 "德国老年人(D80+)"。
IF 3.6 3区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2024-07-17 DOI: 10.1002/gps.6127
André Hajek, Karl Peltzer, Nicola Veronese, Hans-Helmut König, Razak M. Gyasi

Objectives

To examine the association between pet ownership and psychosocial outcomes among the oldest old in Germany during the Covid-19 pandemic.

Methods/Design

Data from the “Old Age in Germany (D80+)” study were used, a large, nationwide representative study covering both individuals living at home and individuals in nursing homes aged 80 years and above (n = 2867 individuals). The telephone interviews were conducted from May to October 2021. Established tools (e.g., “Short Form of the Depression in Old Age Scale”, DIA-S4) were used to quantify the outcomes. Five groups were generated: (1) no pet ownership, (2) having at least one dog (but no other pets), (3) having at least one cat (but no other pets), (4) having at least one other pet (but neither dogs nor cats), (5) having at least two different types of pets (in any combination).

Results

Multiple linear regressions showed that compared to individuals without a pet, individuals having at least one dog had significantly lower loneliness levels (β = −0.21, p < 0.01). In the fully-adjusted models, other forms of pet ownership were not significantly associated with the outcomes examined.

Conclusion

Particularly living with a dog was associated with lower loneliness among the oldest old people in Germany. If living with a dog is in line with the preferences and attitudes of the very old, this could be a strategy for reducing loneliness in this age group.

目的方法/设计:采用了 "德国老年(D80+)"研究的数据,这是一项具有全国代表性的大型研究,涵盖了 80 岁及以上的居家老人和养老院老人(n = 2867 人)。电话访谈于 2021 年 5 月至 10 月进行。研究使用既定工具(如 "老年抑郁量表简表",DIA-S4)对结果进行量化。共分为五组:(1)不养宠物;(2)至少养一只狗(但不养其他宠物);(3)至少养一只猫(但不养其他宠物);(4)至少养一只其他宠物(但既不养狗也不养猫);(5)至少养两种不同类型的宠物(任意组合):在德国,与狗一起生活的老年人的孤独感尤其较低。如果与狗一起生活符合高龄老人的喜好和态度,那么这可能是减少该年龄组孤独感的一种策略。
{"title":"Pet ownership and psychosocial outcomes among the oldest old in Germany during the Covid-19 pandemic. Findings based on the nationally representative “Old Age in Germany (D80+)”","authors":"André Hajek,&nbsp;Karl Peltzer,&nbsp;Nicola Veronese,&nbsp;Hans-Helmut König,&nbsp;Razak M. Gyasi","doi":"10.1002/gps.6127","DOIUrl":"10.1002/gps.6127","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To examine the association between pet ownership and psychosocial outcomes among the oldest old in Germany during the Covid-19 pandemic.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods/Design</h3>\u0000 \u0000 <p>Data from the “Old Age in Germany (D80+)” study were used, a large, nationwide representative study covering both individuals living at home and individuals in nursing homes aged 80 years and above (<i>n</i> = 2867 individuals). The telephone interviews were conducted from May to October 2021. Established tools (e.g., “Short Form of the Depression in Old Age Scale”, DIA-S4) were used to quantify the outcomes. Five groups were generated: (1) no pet ownership, (2) having at least one dog (but no other pets), (3) having at least one cat (but no other pets), (4) having at least one other pet (but neither dogs nor cats), (5) having at least two different types of pets (in any combination).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Multiple linear regressions showed that compared to individuals without a pet, individuals having at least one dog had significantly lower loneliness levels (<i>β</i> = −0.21, <i>p</i> &lt; 0.01). In the fully-adjusted models, other forms of pet ownership were not significantly associated with the outcomes examined.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Particularly living with a dog was associated with lower loneliness among the oldest old people in Germany. If living with a dog is in line with the preferences and attitudes of the very old, this could be a strategy for reducing loneliness in this age group.</p>\u0000 </section>\u0000 </div>","PeriodicalId":14060,"journal":{"name":"International Journal of Geriatric Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gps.6127","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141633456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Geriatric Psychiatry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1